PALUPA Medical is a Startup built by three Scientists (Dr. Marios Pantzaris, Mr. George Loucaides and Dr. Ioannis Patrikios), with the support of Helix Business Incubator, a high-tech innovation incubator. The company was founded in 2006 and the initial goal was to design, plan, and execute a pioneering and innovative research program to support the treatment of Multiple Sclerosis (MS) by investigating the safety and therapeutic effect of a novel and innovative nutritional formula. During the initial period, the company got involved in designing and executing all components of the Drug Development Process such as:
- Application and approval by the Cyprus National Bioethics committee to perform clinical studies on Humans
- Design and execution of Clinical Trials
- Collection and Evaluation of Results
- Final Reports and Dissemination of Results
- Patent application with the USPTO and a PCT
The company continues its activities as a research and innovation company. At present we are involved with the Phase III randomized, placebo-controlled, double-blind, multicenter clinical trial (the “MINERAL” study) of efficacy and safety; the final stage of the intervention development.
Furthermore, PALUPA Medical is involved in the research of other chronic auto-immune, neuron-degenerative deceases such as Parkinson's, Alzheimer etc.
PALUPA Medical is dedicated to researching and developing new pioneering formulations. Our company is ready to give back and share an optimistic smile with those suffering and give meaning to their struggle of survival and in dreaming a better life by developing a novel and innovative nutritional formula that has been clinically tested by PALUPA Medical.